Clare Kahn PhD

Member Board Of Directors at Solid Biosciences
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Greater Philadelphia
Skills

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
Join now
You need to have a working account to view this content.
Join now

Experience

  • Solid Biosciences
    • United States
    • Biotechnology Research
    • 1 - 100 Employee
    • Member Board Of Directors
      • Mar 2021 - Present

      Cambridge, Massachusetts, United States

  • X-VAX Technology Inc
    • R&D Strategy Officer at X-VAX Technology Inc
      • Oct 2019 - Present

      USA

  • Clare Kahn Pharma Consulting LLC
    • President/Owner
      • Jun 2016 - Present

      Philadelphia, PA Consulting in Regulatory Strategy: drug, biologic and vaccine development, registration and lifecycle. Development planning; preparation for Agency interactions/meetings, Advisory Committees Advisory Board role.

  • KBP BioSciences
    • Member of the Advisory Board
      • Aug 2016 - Present

  • X-VAX Tehcnology Inc
    • Chief Regulatory and Preclinical Development Officer
      • Oct 2018 - Oct 2019

      USA

  • The Rittenhouse Plaza
    • President of the Board of Directors
      • May 2014 - Dec 2016

      Philadelphia President and Chair of the Board governing the managment and budget of The Rittenhouse Plaza, a housing cooperative, in Philadelphia.

  • Pfizer
    • United States
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Vice President, Worldwide Regulatory Strategy, Global Innovative Pharma, Pfizer
      • Jan 2014 - Jun 2016

      Collegeville, PA, USA Vice President, Worldwide Safety & Regulatory leading Pfizer’s global regulatory strategic development for the President of the Global Innovative Pharma business and supporting business development for inflammation, rare disease, cardiovascular, metabolic, neuroscience, pain, renal and gender health

    • VP Worldwide Regulatory Strategy, Specialty Care Business
      • Jun 2010 - Dec 2013

      Vice President, Worldwide Safety & Regulatory leading Pfizer’s global regulatory strategic development for the President of the Specialty Care Business and supporting business development for vaccines, inflammation, rare disease, opthalmology, specialty cardiovascular and anti-infectives

  • GSK
    • United Kingdom
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • VP Regulatory Affairs
      • 1999 - 2010

      V.P. variety of therapeutic areas including vaccines, oncology, CV/metabolic, urology

  • The Meadowbrook School
    • Vice President of the Board of Directors
      • Jun 1993 - 1999

      Meadowbrook, PA

  • University of Pennsylvania
    • Assistant Professor of Pharmacology and of Pathology
      • 1981 - 1985

      Philadelphia, PA, USA

Education

  • The Royal Postgaduate Medical School, Hammersmith Hospital, Imperial College London
    Doctor of Philosophy (Ph.D.), Master of Science Biochemistry, Ph.D. clinical pharmacology
    1975 - 1981

Community

You need to have a working account to view this content. Click here to join now